| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 183K | $9.75M | $53.26 | Nov 29, 2024 | Direct |
| HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 8.8K | $158K | $13.87 | Apr 25, 2024 | Direct |
| SUTRO BIOPHARMA, INC. | Director | Common Stock | 50K | $40K | $0.80 | Oct 15, 2025 | Direct |
| ARTELO BIOSCIENCES, INC. | Director | Warrant (right to buy) | 70.4K | Oct 28, 2025 | Direct | ||
| SUTRO BIOPHARMA, INC. | Director | Stock Option (right to buy) | 50K | Jun 6, 2025 | Direct | ||
| ARTELO BIOSCIENCES, INC. | Director | Stock Option (right to buy) | 1.75K | Dec 20, 2024 | Direct | ||
| ARTELO BIOSCIENCES, INC. | Director | Convertible Promissory Note | $111K | Oct 28, 2025 | Direct |